United States · 
Who invested in Alkeus Pharmaceuticals?
Alkeus Pharmaceuticals's investors include MassChallenge, Wellington Management, TCG, TCG Crossover and Bain Capital Life Sciences.
2010201220142016201820202022
$100KSeed$150MSeries BUnited States · Series B startup
Who invested in Alkeus Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$150Mraised across 2 rounds since 2010, from 2 sources
$100KSeed$150MSeries B
- Latest round
- Series B, $150MJun 2023
- Step-upi
- 1500×
- Investors
- 5
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed, $100K Oct 2010
- Biggest round
- $150M Series B · Jun 2023
- Between rounds
- 12.6 years from the last two
The rounds
- Jun 2023Series B$150M4 new1 returning
Source recorded
- Oct 2010
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Bain Capital Life SciencesPrivate equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Alkeus Pharmaceuticals
How much has Alkeus Pharmaceuticals raised?
Alkeus Pharmaceuticals has raised $150M across 2 rounds since 2010.
When did Alkeus Pharmaceuticals last raise?
Alkeus Pharmaceuticals's most recent round was a Series B of $150M in Jun 2023.
What was Alkeus Pharmaceuticals's biggest round?
Its most recent round, $150M in Jun 2023, is also its largest on record.
Who backed Alkeus Pharmaceuticals first?
Alkeus Pharmaceuticals's first round on record, in Oct 2010, was backed by MassChallenge.
What stage is Alkeus Pharmaceuticals at?
Alkeus Pharmaceuticals's latest named round is a Series B, in Jun 2023.
Where is Alkeus Pharmaceuticals based?
Alkeus Pharmaceuticals is based in the United States.
Companies like Alkeus Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.